CSF Pep-LNP
Cat. No.: TDLD-0126-LD76
CSF Pep-LNP
CSF Pep-LNP is an advanced peptide-functionalized lipid nanoparticle (LNP) engineered with CSF Peptide for targeted delivery, leveraging CSF's specific cell targeting ability and LNPs' enhanced stability. It facilitates efficient delivery of therapeutic cargoes, supporting research in targeted drug delivery systems. Please note that this product is intended for research purposes only.
Inquiry
SPECIFIC INQUIRY
Clear All
For Research Use Only. Not for Diagnostic or Treatment Applications.
| Payload Type | mRNA |
| Payload | Empty; EGFP mRNA; Firefly Luciferase mRNA; mCherry mRNA; GFP mRNA; OVA mRNA; EPO mRNA; Renilla Luciferase mRNA; Gaussia Luciferase mRNA; Beta-galactosidase mRNA; Cre mRNA; mOrange mRNA; tdTomato mRNA; EYFP mRNA; Others |
| Capping | Cap 1 |
| Modification | Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other |
| Module Type | Peptide |
| Targeting Module | CSF Peptide |
| Lipid Formulation | DLin-MC3-DMA; LP-01; ALC-0315; SM102; Other |
| Dye | Unlabeled; DiR; DiD; DiO; DiI; Other |
| Application | Control; Targeted Delivery; Gene Therapy |
| Format | Liquid |
| Concentration | 0.1 mg/mL; 0.2 mg/mL; Other (Please Specify) |
| Size | 65-120 nm |
| PDI | < 0.2 |
| Zeta | ± 20.0 mV |
| Encapsulate Efficiency | >90% |
| Shipping | Dry Ice |
| Storage | Store at -80°C |
Related Products
MUC1 CAR mRNA-LNP (TDLD-0825-LD55)
KIT CAR mRNA-LNP (TDLD-0825-LD36)
AXL CAR mRNA-LNP (TDLD-0825-LD56)
c(RGDyK) Pep-LNP (TDLD-0126-LD74)
R6H4 Pep-LNP (TDLD-0825-LD85)
FYLEHPSGGLAVC Pep-LNP (TDLD-0126-LD87)
iRGD Pep-LNP (TDLD-0825-LD80)
KAA Pep-LNP (TDLD-0825-LD103)
Online Inquiry
